VERA
Vera Therapeutics, Inc.
NASDAQ · USHealthcareBiotechnology
$36.99-3.92%
Price as of Jul 20, 2026
VERA capital
Vera Therapeutics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.21x
- Net debt / EBITDA
- 0.11x
Liquidity & coverage
- Current ratio
- 13.64x
- Quick ratio
- 13.64x
- Cash ratio
- 13.22x
- Interest coverage
- -33.98x
- EBITDA / interest
- -31.60x
- Working capital
- $570.7M
Cash & dividend
- FCF / debt
- -3.92x
- Cash flow / debt
- -3.91x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.